Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged StageDefinition Acute Recent HCV seroconversion (prior negative test for hepatitis C in last 12 months) or Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C virus core antigen (HCV-core) in serum/plasma and no detection of hepatitis C virus antibody (negative result) Chronic Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C core antigen (HCV-core) in serum/plasma in two samples taken at least 12 months apart* UnknownAny newly diagnosed case which cannot be classified in accordance with the above definition of acute or chronic infection
Table 2. Number and rate of reported hepatitis C cases per population, EU/EEA, 2010–2014 † † Data presented by date of diagnosis. * Includes the cases reported by countries as acute, chronic or unknown using the differentiation criteria Source: Country reports Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged Country All Acute*Chronic*Unknown* CasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRate Austria Belgium 1151 Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece < Hungary Iceland Ireland Italy Latvia Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden United Kingdom Total EU/EEA
Figure 1. Rate of acute and chronic hepatitis C cases per population, EU/EEA, 2006–2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
Figure 2. Rate of reported acute hepatitis C cases per population, EU/EEA, 2014 Source: Country reports from Austria, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
Figure 3. Rate of reported hepatitis C cases per population, by age and gender, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
Figure 4. Transmission category of hepatitis C cases by acute and chronic disease status, EU/EEA, 2014 Source: Country reports from Austria, Denmark, Estonia, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovakia, Slovenia, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged
Table. Hepatitis C, surveillance systems overview, 2014 Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Hepatitis C. Stockholm: ECDC; © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged Surveillance Data reported byCase definition used characteristics CountryData source LPHO AustriaAT-EpidemiegesetzCoC YYYYEU-2008 BelgiumBE-LABNETSeCYN..Other BulgariaBG-NATIONAL_SURVEILLANCECoH YYYYEU-2008 CroatiaHR-CNIPHCoAYYYYEU-2012 CyprusCY-NOTIFIED_DISEASESCoC NYNNEU-2008 Czech Republic CZ-EPIDATCoCNYYNEU-2008 DenmarkDK-MISCoC NYNNOther EstoniaEE-NAKISCoCYYYNEU-2012 FinlandFI-NIDRCoC YYNNEU-2012 GreeceEL-NOTIFIABLE_DISEASESCoC YYYNEU-2008 HungaryHU-EFRIRCoCYYYNEU-2012 IcelandIS-SUBJECT_TO_REGISTRATIONCoC YYYNEU-2012 IrelandIE-CIDRCoCYYYNEU-2012 ItalyIT-NRSCoC NYYNOther ItalyIT-SEIEVASeCNYYNEU-2012 LatviaLV-BSNCoC YYYYEU-2012 LithuaniaLT-COMMUNICABLE_DISEASESCoCNYNNEU-2012 LuxembourgLU-SYSTEM1CoC NYNNOther MaltaMT-DISEASE_SURVEILLANCECoCYYYYEU-2012 NetherlandsNL-OSIRISCoC YYNNEU-2008 NorwayNO-MSIS_ACoCYYYNEU-2012 PolandPL-NATIONAL_SURVEILLANCECoH NYYNEU-2008 PortugalPT-HEPATITISCCoCNYNNOther RomaniaRO-RNSSyCoC YNYNOther SlovakiaSK-EPISCoCYYYNEU-2012 SloveniaSI-SURVIVALCoC YYYNEU-2012 SwedenSE-SMINETCoCYYYNEU-2012 United Kingdom UK-HEPATITISCCoC YNYNEU-2012